the effect of oral pyridostigmine on ileus after abdominal surgery

Evaluation of the effect of oral pyridostigmine on ileus after abdominal surgery

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180123038484N1

Enrollment

Registered

2018-02-17

Start date

2015-01-21

Completion date

Unknown

Last updated

2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative ileus (poi). Other postprocedural complications and disorders of digestive system

Interventions

Intervention 1: Intervention group: (20 patients) Patients received oral pyridostigmine at a dose of 60 mg twice daily via NG TUBE. Intervention 2: Control group: (20 patients) the control group recei

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: having ileus for more than 3 days the consent to participate in the study

Exclusion criteria

Exclusion criteria: heart rate less than 60 times per minute blood pressure less than 90 mmHg age below 18 years finding mechanical causes for inactivity of the intestines heart problem colon cancer and small bowel cancer

Design outcomes

Primary

Measure	Time frame
Time for effectiveness. Timepoint: each hour. Method of measurement: Researcher-made questioner.;Frequency of effectiveness. Timepoint: each hour. Method of measurement: Researcher-made questioner.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbdobaset Malek Raeisi Nejad

Zahedan University of Medical Sciences

a.malek@zaums.ac.ir+98 54 3522 3101

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026